# Concurrent Hyperthermia and Chemoradiotherapy in LAPC: Phase II Study

> **NCT02439593** · PHASE2 · UNKNOWN · sponsor: **Kantonsspital Aarau** · enrollment: 78 (estimated)

## Conditions studied

- Cancer Pancreas

## Interventions

- **OTHER:** Chemoradiotherapy (CTRT)
- **OTHER:** Thermochemoradiotherapy (CTRTHT)

## Key facts

- **NCT ID:** NCT02439593
- **Lead sponsor:** Kantonsspital Aarau
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-01
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-12-31
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2017-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02439593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02439593, "Concurrent Hyperthermia and Chemoradiotherapy in LAPC: Phase II Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02439593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*